Supernus Pharmaceuticals (SUPN) Beats Q3 Earnings and Revenue Estimates

Supernus Pharmaceuticals (SUPN) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of$ 0.39 per share. This compares to loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 171.79%. A quarter ago, it was expected that this drugmaker would post earnings of$ 0.37 per share when it actually produced earnings of $0.36, delivering a surprise of -2.70%.Over the last four quarters, the ...